Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026

Savyon Diagnostics to Spin Off Nongenetic Lab Business

By HospiMedica staff writers
Posted on 17 Jan 2003
An agreement to organize a new Israeli company to acquire the clinical laboratory diagnostics business of Savyon Diagnostics, Ltd., a subsidiary of Healthcare Technologies (Ashdod, Israel), for around US$1.9 million has been announced by Healthcare Technologies, Savyon, and Dr. More...
Martin Lee, founder and former CEO of Great Smokies Diagnostic Laboratory (Ashville, NC, USA).

Healthcare and Dr. Lee will each own 50% of the newly organized company, and Dr. Lee will serve as CEO. Dr. Lee has a Ph.D. in biochemistry and microbiology. His career has included senior positions at many prominent US laboratories. Dr. Nir Navot, current CEO of Savyon Diagnostics, will continue to manage Savyon's clinical laboratory genetic diagnostics business, with the aim of developing it as a leading provider of molecular biology-based tools for the diagnosis of genetically inherited disease.

"The opportunity to work together with such a distinguished senior veteran of the medical diagnostics industry as Dr. Lee makes us all very excited about the future of this new company that we are now creating,” noted Daniel Kropf, president of Healthcare Technologies.





Related Links:
Healthcare Technologies
Great Smokies Lab

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.